Free tool
Healthcare stocks
We cover 1,012 companies in the Healthcare sector. The median market value in the group is $684.47M, measured across the 1,000 largest of them. Among those 1,000, the median move over the past trading day is +0.73%. 59% of the 963 with a 200-day average trade above it. Price change over the past year runs from −38.7% to +171.6% across the middle 80 percent of the group, with a median of +11.8%. Among those 1,000, 5 companies currently carry a tier A volume signal.
Other lists in this group
Table
1,012 of 2,199 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| R1DY34.SA | Dr. Reddy's Laboratories Limited | 10.25 BRL | −15.29% | −14.30% | −21.76% |
| PODD | Insulet Corporation | $143.05 | −13.30% | −49.44% | −56.52% |
| NUVL | Nuvalent Inc | $123.96 | 0.00% | +22.93% | +67.40% |
| BIO-B | Bio-Rad Laboratories, Inc. | $365.08 | +18.01% | +17.50% | +47.78% |
| AVTR | Avantor, Inc. | $14.42 | +22.62% | +25.83% | +9.16% |
| OSCR | Oscar Health, Inc. | $30.93 | +9.14% | +106.61% | +85.10% |
| TWST | Twist Bioscience Corporation | $151.42 | +74.97% | +367.49% | +452.83% |
| WDH1.DE | Demant A/S | 39.10 EUR | +5.22% | +36.62% | −5.53% |
| DEMANT.CO | Demant A/S | 287.00 DKK | +0.99% | +34.49% | +17.33% |
| SYRE | Spyre Therapeutics, Inc. | $107.36 | +7.32% | +251.08% | +547.53% |
| KRK.WA | Krka, d. d. | 1,110.00 PLN | −2.46% | +29.07% | +31.52% |
| PCVX | Vaxcyte, Inc. | $61.09 | +10.07% | +31.49% | +100.62% |
| QGEN | Qiagen N.V. | $43.65 | +6.26% | −3.41% | −10.74% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.86 | +1.20% | +81.60% | +182.02% |
| IMVT | Immunovant, Inc. | $43.50 | +8.51% | +67.89% | +192.14% |
| QIA.DE | Qiagen N.V. | 36.41 EUR | −0.78% | −4.56% | −11.42% |
| HQY | HealthEquity, Inc. | $105.39 | +6.40% | +15.72% | +20.55% |
| 4523.T | Eisai Co., Ltd. | 4,911.00 JPY | +2.50% | +4.27% | +9.74% |
| BRKR | Bruker Corporation | $56.85 | −5.33% | +18.34% | +64.93% |
| ATR | AptarGroup, Inc. | $134.72 | +1.37% | +10.80% | −2.35% |
| 4151.T | Kyowa Kirin Co., Ltd. | 2,596.00 JPY | −2.26% | +3.26% | +3.09% |
| TGTX | TG Therapeutics, Inc. Common Stock | $56.01 | +0.47% | +91.29% | +96.32% |
| TXG | 10x Genomics, Inc. | $64.72 | +40.94% | +289.41% | +359.99% |
| ALKS | Alkermes plc | $49.21 | −6.68% | +74.13% | +69.69% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $113.35 | +6.80% | +7.94% | +14.26% |
| 6869.T | Sysmex Corporation | 1,957.00 JPY | +19.66% | +29.29% | +5.65% |
| HIMS | Hims & Hers Health, Inc. | $31.75 | +4.99% | −4.97% | −26.15% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | 2,511.00 JPY | +3.89% | +16.57% | +62.22% |
| 2413.T | M3, Inc. | 1,754.00 JPY | −8.67% | −14.21% | −20.12% |
| CAI | Caris Life Sciences, Inc. | $28.01 | +79.21% | +3.82% | −27.21% |
| RHC.AX | Ramsay Health Care Limited | 44.27 AUD | +2.00% | +29.22% | +18.74% |
| HNGE | Hinge Health, Inc. | $89.87 | +19.65% | +97.26% | +63.19% |
| ALK-B.CO | ALK-Abelló A/S | 214.20 DKK | −5.31% | −4.75% | +8.24% |
| SHL.AX | Sonic Healthcare Limited | 20.31 AUD | −7.72% | −7.74% | −11.60% |
| CHE | Chemed Corporation | $543.98 | +6.80% | +28.52% | +19.61% |
| SRRK | Scholar Rock Holding Corporation | $58.25 | +19.05% | +36.10% | +74.77% |
| GETI-B.ST | Getinge AB (publ) | 245.00 SEK | +4.17% | +15.36% | +21.56% |
| PACS | PACS Group, Inc. | $43.94 | −6.67% | +11.21% | +272.69% |
| CGON | CG Oncology, Inc. | $78.95 | +7.39% | +88.92% | +210.58% |
| 3391.T | Tsuruha Holdings Inc. | 2,422.50 JPY | −3.43% | −15.02% | +8.33% |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | 380,000.00 KRW | +3.54% | −46.85% | +13.26% |
| ORKA | Oruka Therapeutics, Inc. | $101.82 | +12.88% | +260.17% | +601.72% |
| 7747.T | Asahi Intecc Co., Ltd. | 4,016.00 JPY | +12.49% | +35.31% | +58.61% |
| RADL3.SA | Raia Drogasil S.A. | 19.59 BRL | +7.82% | −16.98% | +12.04% |
| E2XE34.SA | Exelixis, Inc. | 137.40 BRL | −2.25% | +23.92% | +23.92% |
| HLUN-B.CO | H. Lundbeck A/S | 41.54 DKK | −1.33% | −0.38% | +5.61% |
| LNTH | Lantheus Holdings, Inc. | $100.87 | −6.63% | +49.95% | +79.61% |
| HLUN-A.CO | H. Lundbeck A/S | 41.00 DKK | +12.95% | +14.64% | +26.06% |
| BLTE | Belite Bio, Inc | $161.68 | +2.05% | +1.51% | +154.13% |
| 3088.T | MatsukiyoCocokara & Co. | 2,606.50 JPY | +0.66% | −2.95% | −14.17% |
| COGT | Cogent Biosciences, Inc. | $36.80 | −9.00% | +5.93% | +212.13% |
| COH.AX | Cochlear Limited | 138.52 AUD | +15.55% | −46.26% | −53.16% |
| LQDA | Liquidia Corporation | $70.49 | −16.50% | +124.49% | +168.53% |
| CNTA | Centessa Pharmaceuticals plc | $40.50 | 0.00% | +70.96% | +138.24% |
| AMRX | Amneal Pharmaceuticals, Inc. | $17.92 | −0.94% | +41.55% | +93.10% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $80.20 | +26.23% | +90.93% | +142.74% |
| BLCO | Bausch + Lomb Corporation | $17.25 | +5.96% | +4.04% | +18.72% |
| ERAS | Erasca, Inc. | $17.76 | −5.88% | +394.71% | +1016.98% |
| BLCO.TO | Bausch + Lomb Corporation | 23.84 CAD | +3.79% | +4.61% | +18.08% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $73.47 | −3.07% | −4.26% | +49.03% |
| DNTH | Dianthus Therapeutics, Inc. | $112.11 | +7.29% | +182.54% | +378.90% |
| STVN | Stevanato Group S.p.A. | $22.70 | +14.65% | +10.30% | +3.23% |
| TVTX | Travere Therapeutics, Inc. | $67.01 | +18.23% | +69.56% | +288.91% |
| CTEC.L | Convatec Group PLC | 228.00 GBP | −0.09% | −4.83% | −2.30% |
| RDNT | RadNet, Inc. | $76.86 | +24.96% | +8.33% | +10.45% |
| DFTX | Definium Therapeutics, Inc. | $44.81 | +5.06% | +228.52% | +354.92% |
| T1FX34.SA | Teleflex Incorporated | 69.78 BRL | 0.00% | +3.04% | +0.29% |
| MIRM | Mirum Pharmaceuticals, Inc. | $98.08 | −14.12% | +25.63% | +36.58% |
| TFX | Teleflex Incorporated | $140.18 | +6.97% | +15.16% | +10.85% |
| CRSP | CRISPR Therapeutics AG | $60.90 | +30.32% | +13.26% | +12.51% |
| XENE | Xenon Pharmaceuticals Inc. | $60.42 | −8.15% | +35.81% | +58.42% |
| SECT-B.ST | Sectra AB (publ) | 275.80 SEK | −1.15% | +15.11% | −19.07% |
| LGND | Ligand Pharmaceuticals Incorporated | $281.72 | −5.30% | +48.19% | +77.42% |
| MMED | MiniMed Group, Inc. | $18.92 | +7.07% | +2.33% | +2.33% |
| SHC | Sotera Health Company | $19.51 | +13.17% | +10.29% | +19.04% |
| MMSI | Merit Medical Systems, Inc. | $91.09 | +19.70% | +5.37% | +3.32% |
| GRFS | Grifols, S.A. | $8.09 | +4.39% | −12.45% | −17.62% |
| ACAD | ACADIA Pharmaceuticals Inc. | $30.57 | +20.40% | +16.28% | +20.73% |
| HAE | Haemonetics Corporation | $108.32 | +35.55% | +35.43% | +96.13% |
| DYN | Dyne Therapeutics, Inc. | $26.34 | +2.77% | +42.38% | +102.62% |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | 86,200.00 KRW | +8.43% | −29.86% | −14.48% |
| EWTX | Edgewise Therapeutics, Inc. | $44.21 | +6.27% | +86.15% | +209.16% |
| BLLN | BillionToOne, Inc. | $100.08 | −21.80% | +12.08% | −8.14% |
| LFST | LifeStance Health Group, Inc. | $12.28 | +12.87% | +76.44% | +127.83% |
| 000100.KS | Yuhan Corporation | 86,000.00 KRW | +21.64% | −23.35% | −25.59% |
| WAY | Waystar Holding Corp. | $24.21 | +4.69% | −22.82% | −32.56% |
| HIK.L | Hikma Pharmaceuticals PLC | 1,633.00 GBP | +1.24% | +7.25% | −11.37% |
| ICUI | ICU Medical, Inc. | $182.24 | +12.87% | +31.55% | +44.85% |
| OBCK.DE | Ottobock SE & Co. KGaA I | 59.50 EUR | +4.94% | −0.82% | −0.82% |
| DOCS | Doximity, Inc. | $24.74 | +17.87% | −42.85% | −62.74% |
| RLAY | Relay Therapeutics, Inc. | $20.57 | +10.35% | +151.47% | +486.04% |
| ELVN | Enliven Therapeutics, Inc. | $61.01 | +15.69% | +292.60% | +205.89% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | 539,500.00 KRW | +44.06% | +22.23% | +80.49% |
| CELC | Celcuity Inc. | $92.27 | +12.16% | −8.23% | +87.35% |
| CON | Concentra Group Holdings Parent, Inc. | $34.78 | +9.06% | +80.13% | +49.74% |
| NVST | Envista Holdings Corporation | $27.47 | +3.12% | +26.65% | +30.07% |
| LIVN | LivaNova PLC | $79.41 | −1.45% | +30.95% | +40.92% |
| HTFL | Heartflow, Inc. | $49.89 | +96.65% | +72.21% | +67.19% |
| ITGR | Integer Holdings Corporation | $125.39 | +26.15% | +63.31% | +15.26% |
| INDV | Indivior Pharmaceuticals, Inc. | $35.97 | −10.14% | +0.67% | +49.81% |
| ADPT | Adaptive Biotechnologies Corporation | $26.25 | +16.46% | +64.99% | +107.18% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $37.46 | +92.20% | +228.02% | +340.71% |
| ANN.AX | Ansell Limited | 41.16 AUD | +25.93% | +18.26% | +22.31% |
| 4506.T | Sumitomo Pharma Co., Ltd. | 1,476.50 JPY | +14.24% | −40.00% | −2.73% |
| LEGN | Legend Biotech Corporation | $21.30 | +10.53% | −0.98% | −38.44% |
| TNGX | Tango Therapeutics, Inc. | $24.51 | −8.27% | +174.47% | +264.73% |
| MANE | Veradermics, Incorporated | $102.35 | −8.14% | +171.13% | +171.13% |
| IDYA | IDEAYA Biosciences, Inc. | $42.48 | +15.53% | +25.49% | +71.91% |
| IRTC | iRhythm Holdings, Inc. | $123.09 | +9.75% | −29.75% | −25.71% |
| ABCL | AbCellera Biologics Inc. | $12.50 | +138.10% | +264.43% | +195.51% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | 22.90 EUR | +6.02% | +57.53% | −0.90% |
| RCUS | Arcus Biosciences, Inc. | $31.57 | +13.40% | +35.55% | +211.03% |
| VKTX | Viking Therapeutics, Inc. | $34.17 | −2.01% | −3.53% | +32.19% |
| DNLI | Denali Therapeutics Inc. | $24.93 | +5.77% | +53.23% | +60.12% |
| TLX | Telix Pharmaceuticals Limited | $11.68 | +17.03% | +53.28% | −4.26% |
| MCOV-B.ST | Medicover AB (publ) | 242.00 SEK | +5.91% | +14.26% | −10.12% |
| TLX.AX | Telix Pharmaceuticals Limited | 16.06 AUD | +10.99% | +41.37% | −12.72% |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% |
| 000105.KS | Yuhan Corporation | 71,600.00 KRW | +17.76% | −29.29% | −31.05% |
| CAMX.ST | Camurus AB (publ) | 609.50 SEK | −2.25% | −0.41% | −14.52% |
| CPRX | Catalyst Pharmaceuticals Inc | $31.49 | 0.00% | +36.03% | +52.72% |
| FIE.DE | Fielmann Group AG | 39.40 EUR | −5.06% | −9.74% | −30.39% |
| IOVA | Iovance Biotherapeutics, Inc. | $8.44 | +72.24% | +234.92% | +233.60% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | 1,882.50 JPY | −3.95% | +15.60% | +22.85% |
| 7459.T | MediPal Holdings Corporation | 2,933.00 JPY | −1.26% | +6.35% | +14.74% |
| GRAL | GRAIL, Inc. | $82.54 | +23.62% | −7.12% | +150.69% |
| OGN | Organon & Co. | $13.75 | +1.55% | +90.67% | +52.78% |
| A2LC34.SA | Alcon Inc. | 38.00 BRL | +11.50% | −13.23% | −12.91% |
| GPCR | Structure Therapeutics Inc. | $49.92 | +2.53% | −26.72% | +168.82% |
| QURE | uniQure N.V. | $51.05 | +33.60% | +118.26% | +228.30% |
| OPCH | Option Care Health, Inc. | $23.64 | +8.39% | −26.67% | −15.75% |
| VCYT | Veracyte, Inc. Common Stock | $44.04 | −20.81% | +3.89% | +49.04% |
| NHC | National HealthCare Corporation | $224.73 | −0.60% | +73.01% | +103.48% |
| PLSE | Pulse Biosciences, Inc. | $49.13 | +49.83% | +266.92% | +197.94% |
| ZEAL.CO | Zealand Pharma A/S | 309.40 DKK | +1.14% | −32.75% | −27.05% |
| IMNM | Immunome, Inc. | $29.39 | +30.14% | +41.14% | +196.22% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $9.00 | +34.53% | +164.71% | +275.00% |
| MBX | MBX Biosciences, Inc. | $68.62 | +11.94% | +124.62% | +394.02% |
| 3349.T | COSMOS Pharmaceutical Corporation | 6,573.00 JPY | −0.59% | −14.46% | −27.10% |
| NAMS | NewAmsterdam Pharma Company N.V. | $27.34 | −9.53% | −22.33% | +10.69% |
| AFX.DE | Carl Zeiss Meditec AG | 32.30 EUR | +12.39% | −16.64% | −23.23% |
| WRBY | Warby Parker Inc. | $26.00 | +4.59% | +14.94% | −0.61% |
| BIOA-B.ST | BioArctic AB (publ) | 329.80 SEK | +2.23% | +6.74% | +20.03% |
| CLDX | Celldex Therapeutics, Inc. | $41.22 | +15.62% | +52.61% | +87.96% |
| TMDX | TransMedics Group, Inc. | $93.60 | +26.01% | −23.71% | −18.59% |
| VIRP.PA | Virbac SA | 329.00 EUR | −4.78% | −6.93% | −2.81% |
| BEAM | Beam Therapeutics Inc. | $31.03 | +23.77% | +14.33% | +88.75% |
| AMBU-B.CO | Ambu A/S | 78.25 DKK | +7.78% | −9.28% | −19.61% |
| TARS | Tarsus Pharmaceuticals, Inc. | $71.45 | +18.85% | −11.54% | +26.21% |
| 7649.T | Sugi Holdings Co.,Ltd. | 2,729.00 JPY | −6.22% | −25.12% | −28.33% |
| IRON | Disc Medicine, Inc. | $82.41 | +10.45% | +4.20% | +38.71% |
| ARQT | Arcutis Biotherapeutics, Inc. | $24.86 | −10.70% | −14.28% | +58.44% |
| ASKER.ST | Asker Healthcare Group AB (publ) | 76.10 SEK | −2.93% | −7.03% | −22.60% |
| HYPE3.SA | Hypera S.A. | 21.80 BRL | +3.51% | −5.49% | −4.08% |
| ALMS | Alumis Inc. | $23.96 | −11.52% | +167.56% | +388.98% |
| AVAH | Aveanna Healthcare Holdings Inc. | $13.59 | +40.54% | +68.19% | +82.91% |
| ZLAB | Zai Lab Limited | $26.17 | +40.40% | +51.01% | −23.10% |
| BKD | Brookdale Senior Living Inc. | $12.20 | −21.14% | +12.55% | +59.90% |
| SLS | SELLAS Life Sciences Group, Inc. | $14.09 | +29.98% | +223.91% | +637.70% |
| ALHC | Alignment Healthcare, Inc. | $13.59 | −27.21% | −32.79% | −12.77% |
| ACHC | Acadia Healthcare Company, Inc. | $29.87 | −8.09% | +109.03% | +34.73% |
| 9989.T | Sundrug Co.,Ltd. | 3,741.00 JPY | −3.90% | −11.25% | −17.00% |
| RGC | Regencell Bioscience Holdings Limited | $5.54 | −4.97% | −73.03% | −54.89% |
| VRDN | Viridian Therapeutics, Inc. | $24.18 | +22.74% | −21.19% | +30.21% |
| ATAI | AtaiBeckley Inc. | $7.44 | +3.77% | +92.25% | +56.96% |
| NRIX | Nurix Therapeutics, Inc. | $26.95 | +15.02% | +49.22% | +178.70% |
| EBO.AX | EBOS Group Limited | 18.77 AUD | +4.45% | −18.40% | −35.38% |
| PRVA | Privia Health Group, Inc. | $21.20 | −14.07% | −9.63% | −0.93% |
| AXGN | AxoGen, Inc. Common Stock | $49.93 | +21.37% | +61.06% | +237.59% |
| CDNA | CareDx, Inc. | $50.80 | +39.71% | +165.41% | +298.43% |
| SUPN | Supernus Pharmaceuticals, Inc. | $45.36 | −3.45% | −8.31% | +2.09% |
| PHVS | Pharvaris N.V. | $37.31 | +9.83% | +40.90% | +57.76% |
| RARE | Ultragenyx Pharmaceutical Inc. | $26.46 | −1.60% | +12.12% | −9.60% |
| WGS | GeneDx Holdings Corp. | $87.41 | +44.38% | −33.93% | −28.28% |
| B72.DE | AtaiBeckley Inc. | 6.45 EUR | +2.38% | +88.27% | +57.16% |
| CURA.TO | Curaleaf Holdings, Inc. | 13.57 CAD | +7.44% | +279.05% | +225.42% |
| EMEIS.PA | EMEIS | 14.07 EUR | +3.46% | −3.76% | +10.18% |
| PGEN | Precigen, Inc. | $7.28 | +34.32% | +70.09% | +82.91% |
| BV3.DE | BAVARIAN NORDIC N | 28.96 EUR | +20.97% | +12.03% | +14.47% |
| BAVA.CO | Bavarian Nordic A/S | 213.00 DKK | +19.39% | +10.48% | −10.13% |
| 2784.T | Alfresa Holdings Corporation | 2,327.00 JPY | −3.60% | −4.09% | +7.97% |
| TRVI | Trevi Therapeutics, Inc. | $17.95 | −0.94% | +50.97% | +146.57% |
| VERA | Vera Therapeutics, Inc. | $35.28 | +0.28% | −27.44% | +65.32% |
| NEOG | Neogen Corporation | $11.64 | +24.63% | +66.29% | +107.86% |
| BHC.TO | Bausch Health Companies Inc. | 9.31 CAD | +46.85% | −6.15% | −8.00% |
| NKTR | Nektar Therapeutics | $74.96 | +5.06% | +72.64% | +176.20% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $9.83 | +2.61% | +31.07% | +17.16% |
| BHC | Bausch Health Companies Inc. | $6.73 | +50.22% | −6.66% | −7.81% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | 4,184.00 JPY | +5.79% | −6.48% | +6.99% |
| NUVB | Nuvation Bio Inc. | $7.10 | +6.61% | −17.25% | +146.53% |
| KOD | Kodiak Sciences Inc. | $39.46 | −5.85% | +51.65% | +316.68% |
| ATRC | AtriCure, Inc. | $48.68 | +30.26% | +23.96% | +28.65% |
| PBH | Prestige Consumer Healthcare Inc. | $51.45 | +2.08% | −15.96% | −21.64% |
| RAPP | Rapport Therapeutics, Inc. | $51.17 | +21.47% | +82.03% | +249.76% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | 110.60 EUR | +15.57% | +65.89% | +63.50% |
| ONT.L | Oxford Nanopore Technologies plc | 166.70 GBP | +49.78% | +30.23% | −14.60% |
| DMP.DE | Dermapharm Holding SE | 39.80 EUR | −4.67% | +3.24% | +14.86% |
| BFLY | Butterfly Network, Inc. | $9.04 | +27.86% | +141.07% | +483.23% |
| OCUL | Ocular Therapeutix, Inc. | $10.88 | +25.93% | −7.95% | −8.34% |
| GRDN | Guardian Pharmacy Services, Inc. | $37.30 | −10.03% | +26.31% | +42.20% |
| UFPT | UFP Technologies, Inc. | $304.21 | +22.35% | +36.17% | +37.69% |
| MLYS | Mineralys Therapeutics, Inc. | $26.34 | −3.20% | −26.24% | +78.70% |
| 009420.KS | Hanall Biopharma Co., Ltd. | 63,300.00 KRW | +40.04% | +50.00% | +108.57% |
| COAG | Hemab Therapeutics Holdings, Inc. | $49.65 | −1.47% | +46.03% | +46.03% |
| ALMR | Alamar Biosciences, Inc. | $33.02 | +35.33% | +50.09% | +50.09% |
| GENB | Generate Biomedicines, Inc. | $20.38 | +48.98% | +61.11% | +61.11% |
| HRMY | Harmony Biosciences Holdings, Inc. | $38.95 | +8.16% | +4.20% | +4.09% |
| URGN | UroGen Pharma Ltd. | $46.36 | +11.82% | +104.14% | +150.59% |
| EKTA-B.ST | Elekta AB (publ) | 55.60 SEK | +13.75% | +0.06% | +19.21% |
| ADUS | Addus HomeCare Corporation | $121.09 | +4.70% | +13.61% | +3.81% |
| 008930.KS | Hanmi Science Co., Ltd. | 45,400.00 KRW | +33.73% | +25.36% | +10.13% |
| MSB.AX | Mesoblast Limited | 2.40 AUD | +16.26% | −13.54% | −3.82% |
| MESO | Mesoblast Limited | $17.19 | +18.06% | −5.34% | +9.42% |
| AUPH | Aurinia Pharmaceuticals Inc. | $16.75 | +10.05% | +9.12% | +38.03% |
| VCEL | Vericel Corporation | $43.22 | −4.63% | +21.37% | +20.76% |
| ZBIO | Zenas BioPharma, Inc. | $33.77 | +2.89% | −2.12% | +103.93% |
| CLOV | Clover Health Investments, Corp. | $4.13 | −3.28% | +71.37% | +56.14% |
| MD | Pediatrix Medical Group, Inc. | $26.99 | +3.25% | +26.77% | +58.21% |
| XRAY | DENTSPLY SIRONA Inc. | $10.97 | −15.75% | −2.66% | −21.70% |
| NEO | NeoGenomics, Inc. | $16.79 | +27.78% | +42.77% | +160.31% |
| XNCR | Xencor, Inc. Common Stock | $29.30 | +47.53% | +96.38% | +265.79% |
| EXE.TO | Extendicare Inc. | 31.70 CAD | −17.30% | +51.39% | +147.28% |
| BHVN | Biohaven Ltd. | $14.38 | −0.90% | +32.66% | −3.75% |
| 9987.T | Suzuken Co., Ltd. | 5,109.00 JPY | −3.28% | −17.12% | −11.16% |
| STOK | Stoke Therapeutics, Inc. | $33.46 | +14.16% | +8.28% | +77.32% |
| CLOV34.SA | Clover Health Investments, Corp. | 20.84 BRL | −8.68% | +57.16% | +44.32% |
| ESTA | Establishment Labs Holdings Inc. | $72.15 | −21.66% | +4.81% | +77.45% |
| GN.CO | GN Store Nord A/S | 93.12 DKK | −0.64% | −15.27% | −19.72% |
| KLRA | Kailera Therapeutics, Inc. | $17.75 | +1.54% | −31.73% | −31.73% |
| ADMA | ADMA Biologics, Inc. | $9.72 | +14.62% | −45.64% | −42.86% |
| PVLA | Palvella Therapeutics, Inc. | $148.24 | +4.56% | +47.83% | +195.71% |
| 302440.KS | SK bioscience Co.,Ltd. | 37,600.00 KRW | +11.24% | −21.67% | −22.23% |
| HCM | HUTCHMED (China) Limited | $12.26 | +10.25% | −10.18% | −23.04% |
| HCM.L | HUTCHMED (China) Limited | 178.00 GBP | +0.85% | −12.75% | −21.24% |
| NANO.PA | Nanobiotix S.A. | 34.14 EUR | +3.96% | +79.68% | +341.09% |
| NBTX | Nanobiotix S.A. | $41.51 | +3.31% | +87.57% | +321.42% |
| ALIF-B.ST | AddLife AB (publ) | 162.40 SEK | +0.74% | +8.24% | −7.56% |
| GNS.L | Genus plc | 2,288.00 GBP | +3.16% | −10.09% | −13.32% |
| NEU.AX | Neuren Pharmaceuticals Limited | 22.51 AUD | +32.02% | +19.04% | +18.47% |
| PIII | P3 Health Partners Inc. | $10.03 | −4.29% | +186.57% | +35.72% |
| CMPS | COMPASS Pathways plc | $14.88 | +32.03% | +127.18% | +224.89% |
| NVCR | NovoCure Limited | $17.62 | +3.46% | +34.30% | +50.60% |
| SEM | Select Medical Holdings Corp | $16.51 | −0.12% | +12.30% | +26.87% |
| 6960.T | Fukuda Denshi Co., Ltd. | 11,900.00 JPY | +2.23% | +56.36% | +78.59% |
| TSHA | Taysha Gene Therapies, Inc. | $6.20 | +11.91% | +18.10% | +112.33% |
| PRGO | Perrigo Company plc | $14.48 | +42.80% | +6.59% | −36.97% |
| EMBLA.CO | Embla Medical hf | 30.25 DKK | +6.89% | −5.47% | −5.76% |
| SRPT | Sarepta Therapeutics, Inc. | $18.92 | +19.07% | −11.22% | +4.76% |
| GHRS | GH Research PLC | $28.92 | +4.22% | +118.43% | +119.42% |
| PGNY | Progyny, Inc. | $25.45 | −19.44% | −1.13% | +9.98% |
| S1RP34.SA | Sarepta Therapeutics, Inc. | 4.82 BRL | +15.04% | −17.18% | −2.43% |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +0.71% | +15.22% | +8.44% |
| SNDA | Sonida Senior Living, Inc. | $40.97 | −4.32% | +28.31% | +57.21% |
| FLRY3.SA | Fleury S.A. | 18.64 BRL | +12.76% | +25.69% | +39.13% |
| ZYME | Zymeworks Inc. | $27.47 | +19.43% | +3.19% | +88.54% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $33.90 | −8.30% | +24.72% | −9.02% |
| LKFT | Lakefront Biotherapeutics NV | $29.70 | +5.58% | −9.92% | −5.53% |
| SEPN | Septerna, Inc. | $41.30 | +23.32% | +47.61% | +245.32% |
| IMCR | Immunocore Holdings plc | $37.40 | +10.75% | +10.72% | +14.76% |
| RXRX | Recursion Pharmaceuticals, Inc. | $3.56 | +18.27% | −15.24% | −26.29% |
| NTLA | Intellia Therapeutics, Inc. | $13.51 | +26.62% | +46.69% | +18.72% |
| DMRA | Damora Therapeutics, Inc. | $30.62 | +4.01% | +40.33% | +800.59% |
| GXE.DE | Lakefront Biotherapeutics NV | 24.68 EUR | +0.41% | −12.36% | −44.50% |
| ALVO-SDB.ST | Alvotech SDB | 49.65 SEK | +55.89% | +8.57% | −34.75% |
| ASTH | Astrana Health, Inc. | $37.61 | −1.52% | +49.13% | +25.66% |
| PSNL | Personalis, Inc. | $17.25 | +43.99% | +119.75% | +267.02% |
| SGRY | Surgery Partners, Inc. | $14.05 | −7.38% | −7.93% | −39.02% |
| BLFS | BioLife Solutions, Inc. | $37.22 | +24.94% | +55.80% | +45.11% |
| VIR | Vir Biotechnology, Inc. | $10.71 | +21.70% | +80.30% | +144.52% |
| INBX | Inhibrx Biosciences, Inc. | $122.72 | +48.84% | +63.54% | +390.10% |
| LMAT | LeMaitre Vascular, Inc. | $78.97 | −20.18% | −1.03% | −18.51% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | 82.60 EUR | +8.68% | +53.24% | +52.14% |
| ETON | Eton Pharmaceuticals, Inc. | $63.05 | +49.02% | +287.76% | +268.93% |
| ALVO | Alvotech | $5.05 | +63.96% | +1.00% | −39.30% |
| 4540.T | Tsumura & Co. | 3,799.00 JPY | −3.31% | −5.99% | +9.38% |
| INSP | Inspire Medical Systems, Inc. | $61.07 | +19.91% | −33.81% | −34.28% |
| SNDX | Syndax Pharmaceuticals, Inc. | $19.92 | −2.92% | −6.48% | +27.20% |
| ATT.ST | Attendo AB (publ) | 117.70 SEK | +6.42% | +48.97% | +75.11% |
| ANIP | ANI Pharmaceuticals, Inc. | $75.65 | −3.47% | −3.54% | −16.24% |
| FTRE | Fortrea Holdings Inc. | $18.27 | −4.84% | +8.69% | +106.21% |
| ANAB | AnaptysBio, Inc. | $58.37 | +8.88% | +94.78% | +335.60% |
| AVLN | Avalyn Pharma Inc. | $38.20 | +38.31% | +29.54% | +29.54% |
| MAZE | Maze Therapeutics, Inc. | $30.42 | +6.03% | −23.51% | +128.55% |
| 7716.T | Nakanishi Inc. | 3,215.00 JPY | +4.38% | +61.15% | +55.31% |
| CLARI.PA | Clariane SE | 4.06 EUR | +2.37% | +3.31% | −7.85% |
| SIA.TO | Sienna Senior Living Inc. | 21.47 CAD | −6.54% | +6.94% | +25.31% |
| ABSI | Absci Corporation | $9.63 | +27.38% | +166.76% | +279.13% |
| 4DX.AX | 4DMedical Limited | 3.84 AUD | +18.15% | −15.42% | +652.94% |
| FBRX | Forte Biosciences, Inc. | $76.97 | +0.61% | +226.01% | +580.25% |
| BCAX | Bicara Therapeutics Inc. | $24.58 | −11.61% | +50.06% | +117.14% |
| 8129.T | Toho Holdings Co., Ltd. | 3,973.00 JPY | −5.85% | −13.10% | −22.82% |
| 8086.T | Nipro Corporation | 1,580.00 JPY | −2.89% | +7.33% | +6.42% |
| AGL | agilon health, inc. | $96.11 | −2.36% | +470.39% | +178.58% |
| TRAX | First Tracks Biotherapeutics, Inc. | $45.11 | +7.33% | +137.42% | +137.42% |
| ARDT | Ardent Health, Inc. | $11.30 | +3.20% | +30.79% | −10.95% |
| XERS | Xeris Biopharma Holdings, Inc. | $8.74 | +6.46% | +18.91% | +12.48% |
| TYRA | Tyra Biosciences, Inc. | $26.69 | −14.07% | −0.37% | +122.42% |
| OMCL | Omnicell, Inc. | $33.22 | −19.93% | −26.41% | +0.39% |
| KMTS | Kestra Medical Technologies, Ltd. | $26.92 | +17.97% | +10.37% | +51.92% |
| HCSG | Healthcare Services Group, Inc. | $22.94 | −0.04% | +32.22% | +48.10% |
| LBRX | LB Pharmaceuticals Inc | $48.80 | +40.31% | +138.75% | +182.08% |
| AAPG | Ascentage Pharma Group Internat | $16.79 | −11.12% | −36.33% | −61.38% |
| NVAX | Novavax, Inc. | $9.44 | +26.03% | +32.40% | +25.53% |
| BONEX.ST | Bonesupport Holding AB (publ) | 219.20 SEK | +2.05% | +23.15% | −25.64% |
| AVBP | ArriVent BioPharma, Inc. | $31.35 | +3.95% | +50.72% | +62.02% |
| DIA.WA | Diagnostyka S.A. | 166.50 PLN | +0.54% | −3.70% | −17.53% |
| CNMD | CONMED Corporation | $51.13 | +17.51% | +26.18% | −5.45% |
| INVA | Innoviva, Inc. | $21.17 | −0.61% | +6.54% | +7.14% |
| 4516.T | Nippon Shinyaku Co., Ltd. | 3,609.00 JPY | +0.81% | −34.02% | +18.84% |
| 6849.T | Nihon Kohden Corporation | 1,520.50 JPY | −5.73% | −9.30% | −5.62% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | 58.02 BRL | +4.58% | +25.99% | +301.52% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $22.22 | +29.41% | +3.11% | +83.48% |
| SDGR | Schrödinger, Inc. | $19.99 | +30.82% | +11.18% | +2.30% |
| REPL | Replimune Group, Inc. | $15.80 | +83.08% | +77.53% | +187.80% |
| AKTS | Aktis Oncology, Inc. | $26.69 | +10.24% | +19.15% | +19.15% |
| INNV | InnovAge Holding Corp. | $10.92 | −4.88% | +110.40% | +197.55% |
| PYC.AX | PYC Therapeutics Limited | 2.12 AUD | +30.46% | +28.10% | +63.71% |
| CGEM | Cullinan Therapeutics, Inc. | $22.95 | +31.67% | +126.78% | +200.39% |
| AMBEA.ST | Ambea AB (publ) | 170.50 SEK | +19.48% | +25.09% | +32.95% |
| NOLA-B.ST | Nolato AB (publ) | 51.70 SEK | +7.04% | −10.45% | −8.30% |
| ENOV | Enovis Corporation | $25.58 | −9.45% | −3.51% | −17.46% |
| OMDA | Omada Health, Inc. | $23.94 | +16.33% | +60.67% | +14.00% |
| PAHC | Phibro Animal Health Corporation | $35.93 | +1.96% | −3.45% | +13.43% |
| RDC.DE | Redcare Pharmacy NV | 61.30 EUR | −9.65% | −7.19% | −31.39% |
| AZTA | Azenta, Inc. | $33.21 | +20.68% | −0.54% | +7.96% |
| KALV | KalVista Pharmaceuticals Inc | $27.00 | 0.00% | +74.64% | +107.85% |
| ATEC | Alphatec Holdings, Inc. | $9.33 | +7.61% | −55.06% | −41.10% |
| MGTX | MeiraGTx Holdings plc | $14.92 | +21.30% | +91.04% | +96.83% |
| ANRO | Alto Neuroscience, Inc. | $36.31 | +30.28% | +118.87% | +821.57% |
| GDS.PA | Ramsay Générale de Santé SA | 11.10 EUR | +3.26% | +18.84% | +11.00% |
| 4483.T | JMDC Inc. | 3,430.00 JPY | +6.85% | −11.68% | −18.41% |
| 3148.T | Create SD Holdings Co., Ltd. | 3,450.00 JPY | +0.29% | +4.76% | +3.09% |
| OMER | Omeros Corporation | $19.28 | +70.02% | +17.70% | +343.22% |
| ORIC | ORIC Pharmaceuticals, Inc. | $13.83 | +15.06% | +69.28% | +43.76% |
| JBIO | Jade Biosciences, Inc. | $21.84 | +9.47% | +54.24% | +176.46% |
| F9L.F | Joincare Pharmaceutical Group Industry Co.,Ltd. | 6.50 EUR | −2.99% | −48.41% | −48.41% |
| 9627.T | Ain Holdings Inc. | 6,259.00 JPY | +4.09% | −3.94% | +4.41% |
| 3360.T | Ship Healthcare Holdings, Inc. | 2,383.50 JPY | −5.02% | −7.28% | +9.23% |
| P1RG34.SA | Perrigo Company plc | 50.71 BRL | −1.59% | −31.71% | −59.77% |
| VITR.ST | Vitrolife AB (publ) | 91.30 SEK | +5.55% | −30.65% | −31.27% |
| DRTS | Alpha Tau Medical Ltd. | $14.70 | +20.39% | +204.35% | +357.94% |
| CHEMM.CO | ChemoMetec A/S | 487.00 DKK | +17.86% | −27.80% | −4.56% |
| UPR.L | Uniphar plc | 360.00 GBP | −6.01% | +20.41% | +4.35% |
| MNKD | MannKind Corporation | $4.16 | +5.32% | −25.71% | +6.67% |
| PNTG | The Pennant Group, Inc. | $38.25 | −7.47% | +37.44% | +55.24% |
| MLTX | MoonLake Immunotherapeutics | $15.56 | −21.73% | +30.21% | −71.52% |
| REG.AX | Regis Healthcare Limited | 6.15 AUD | −1.60% | −10.32% | −19.77% |
| AMN | AMN Healthcare Services, Inc. | $33.91 | +1.38% | +124.27% | +63.90% |
| IART | Integra LifeSciences Holdings Corporation | $16.79 | −14.03% | +39.80% | +17.66% |
| VOR | Vor Biopharma Inc. | $24.01 | +23.51% | +106.27% | −41.72% |
| SPI.L | Spire Healthcare Group plc | 234.50 GBP | +0.43% | +38.77% | +5.16% |
| CRON | Cronos Group Inc. | $3.51 | +22.73% | +30.00% | +35.52% |
| CRON.TO | Cronos Group Inc. | 4.85 CAD | +19.46% | +31.44% | +34.72% |
| SPTX | Seaport Therapeutics, Inc. | $24.83 | +20.89% | +25.15% | +25.15% |
| AORT | Artivion, Inc. | $26.38 | +1.07% | −40.67% | −39.45% |
| NUTX | Nutex Health Inc. | $188.10 | +26.50% | +26.93% | +110.14% |
| IMTX | Immatics N.V. | $9.24 | +7.07% | −11.58% | +76.67% |
| ODTX | Odyssey Therapeutics, Inc. | $26.23 | +37.83% | +59.74% | +59.74% |
| 4544.T | H.U. Group Holdings, Inc. | 3,678.00 JPY | +5.93% | +9.61% | +11.45% |
| RYM.AX | RYM FPO NZX [RYM] | 1.73 AUD | −8.73% | −32.88% | −28.42% |
| BIOG-B.ST | BioGaia AB (publ) | 116.30 SEK | +0.87% | +14.26% | +14.81% |
| GLUE | Monte Rosa Therapeutics, Inc. | $14.56 | −35.46% | −4.90% | +217.21% |
| CERT | Certara, Inc. | $8.14 | +5.03% | −6.86% | −24.70% |
| PRCT | PROCEPT BioRobotics Corporation | $21.60 | +22.10% | −29.78% | −45.05% |
| 2175.T | SMS Co., Ltd. | 2,404.00 JPY | +2.21% | +81.25% | +56.85% |
| SANA | Sana Biotechnology, Inc. | $4.10 | +25.00% | −2.15% | +22.39% |
| CRVS | Corvus Pharmaceuticals, Inc. | $14.56 | +12.69% | +98.91% | +167.16% |
| 4553.T | Towa Pharmaceutical Co., Ltd. | 3,950.00 JPY | −4.13% | +10.32% | +34.73% |
| CVSG.L | CVS Group plc | 1,292.00 GBP | +2.95% | +1.41% | +0.47% |
| 6523.T | PHC Holdings Corporation | 1,541.00 JPY | +39.84% | +39.19% | +59.08% |
| 4887.T | Sawai Group Holdings Co., Ltd. | 1,632.00 JPY | −2.57% | −30.18% | −12.23% |
| GDRX | GoodRx Holdings, Inc. | $3.48 | +13.93% | +26.36% | −18.24% |
| AVNS | Avanos Medical Inc | $24.99 | +0.04% | +123.52% | +115.43% |
| STAA | STAAR Surgical Company | $23.18 | +1.00% | −1.78% | −15.68% |
| USPH | U.S. Physical Therapy, Inc. | $77.32 | +0.89% | −0.67% | −7.75% |
| TTALO.HE | Terveystalo Oyj | 7.68 EUR | +5.06% | −17.28% | −24.58% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | 14.70 EUR | +14.84% | +15.81% | +27.68% |
| SVRA | Savara Inc. | $5.60 | +3.13% | −0.71% | +78.34% |
| LMRI | Lumexa Imaging Holdings, Inc. | $12.07 | +9.23% | −31.23% | −34.83% |
| 2160.T | GNI Group Ltd. | 2,765.00 JPY | +12.58% | +20.74% | +4.54% |
| JANX | Janux Therapeutics, Inc. | $18.68 | +19.97% | +36.85% | −18.82% |
| T2DH34.SA | Teladoc Health, Inc. | 32.09 BRL | −29.80% | −15.77% | −23.05% |
| IVA.PA | Inventiva S.A. | 3.96 EUR | +0.64% | −2.22% | −14.58% |
| TDOC | Teladoc Health, Inc. | $6.19 | −30.53% | −12.20% | −19.30% |
| SNZ.AX | Summerset Group Holdings Limited | 6.45 AUD | −7.99% | −38.01% | −32.53% |
| PHIL.MI | Philogen S.p.A. | 23.35 EUR | −2.71% | +3.88% | +2.12% |
| IRMD | IRADIMED CORPORATION | $87.87 | −7.58% | −7.60% | +24.31% |
| SPH.WA | Sopharma AD | 8.40 PLN | +17.32% | −34.12% | −33.66% |
| OPK | OPKO Health, Inc. | $1.49 | +20.16% | +17.32% | +7.19% |
| IVA | Inventiva S.A. | $4.69 | +1.96% | −1.47% | +0.54% |
| 7476.T | AS ONE Corporation | 2,477.00 JPY | −2.09% | +4.79% | +2.10% |
| KURA | Kura Oncology, Inc. | $13.59 | +33.89% | +31.49% | +77.65% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | 89.55 BRL | +3.11% | +36.80% | +36.80% |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | 4,125.00 JPY | −2.71% | −8.70% | −0.90% |
| 006280.KS | GC Biopharma Corp. | 129,300.00 KRW | +7.21% | −18.07% | −1.88% |
| AVTX | Avalo Therapeutics, Inc. | $19.74 | +1.23% | +15.98% | +110.00% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $2.34 | +4.93% | +105.26% | +107.08% |
| CADL | Candel Therapeutics, Inc. | $13.60 | +36.55% | +150.00% | +138.18% |
| WVE | Wave Life Sciences, Inc. | $5.25 | −11.32% | −67.08% | −47.18% |
| QDEL | QuidelOrtho Corporation | $15.05 | −10.58% | −47.71% | −45.57% |
| GUBRA.CO | Gubra A/S | 378.60 DKK | +1.01% | −29.10% | −2.92% |
| GXI.DE | Gerresheimer AG | 28.02 EUR | +5.58% | +0.79% | −33.73% |
| MEDCL.PA | MedinCell S.A. | 24.30 EUR | −3.72% | −1.70% | +40.14% |
| ABUS | Arbutus Biopharma Corporation | $5.20 | +17.91% | +9.01% | +48.57% |
| CLYM | Climb Bio Inc | $17.84 | +39.48% | +375.73% | +619.35% |
| CSTL | Castle Biosciences, Inc. | $35.00 | +43.21% | −9.19% | +70.15% |
| PCRX | Pacira BioSciences, Inc. | $25.53 | −3.55% | +4.37% | +0.67% |
| 7730.T | Mani, Inc. | 1,617.00 JPY | +6.80% | +11.06% | +32.50% |
| 069620.KS | Daewoong Pharmaceutical Co., Ltd | 123,300.00 KRW | −2.07% | −25.72% | −10.28% |
| GERN | Geron Corporation | $1.55 | +4.73% | +17.42% | +9.15% |
| SLDB | Solid Biosciences Inc. | $9.89 | +25.35% | +81.47% | +76.61% |
| DSGN | Design Therapeutics, Inc. | $15.68 | +31.99% | +72.31% | +201.54% |
| ANNX | Annexon, Inc. | $5.15 | +0.39% | +9.81% | +139.53% |
| ARDX | Ardelyx, Inc. | $3.78 | −25.30% | −38.54% | −37.62% |
| IMMX | Immix Biopharma, Inc. | $14.47 | +66.51% | +166.48% | +589.05% |
| EUZ.DE | Eckert & Ziegler SE | 13.65 EUR | −0.29% | −9.06% | −23.06% |
| BVS | Bioventus Inc. | $14.08 | +13.09% | +95.28% | +89.25% |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | 4,030.00 JPY | +3.07% | +2.67% | +10.48% |
| VETO.PA | Vetoquinol SA | 70.50 EUR | −3.16% | −16.47% | −6.50% |
| OLMA | Olema Pharmaceuticals, Inc. | $10.91 | −9.16% | −56.84% | +95.17% |
| HELP | Cybin D/B/A Helus Pharma | $13.99 | +81.62% | +68.90% | +92.90% |
| DBVT | DBV Technologies S.A. | $14.97 | +7.70% | −21.42% | +52.91% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $21.98 | +14.60% | −16.93% | −26.32% |
| NEU.WA | NEUCA S.A. | 774.00 PLN | +2.52% | −7.31% | +17.99% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 280.00 SEK | +11.46% | +54.61% | +60.46% |
| ACRS | Aclaris Therapeutics, Inc. | $6.54 | +21.69% | +126.91% | +263.06% |
| DBV.PA | DBV Technologies S.A. | 2.44 EUR | +2.78% | −25.33% | +54.11% |
| 3046.T | JINS HOLDINGS Inc. | 6,310.00 JPY | −6.38% | +15.77% | −21.01% |
| CBLL | CeriBell, Inc. | $23.95 | +32.10% | +12.44% | +109.35% |
| PHN.MI | Pharmanutra S.p.A. | 82.20 EUR | −1.08% | +54.86% | +71.93% |
| B2RK34.SA | Bruker Corporation | 30.63 BRL | −0.49% | +63.27% | +63.27% |
| 4587.T | PeptiDream Inc. | 1,135.00 JPY | +22.00% | −29.98% | −28.26% |
| SGP | SpyGlass Pharma, Inc. | $26.60 | +27.76% | +0.76% | +0.76% |
| SYNSAM.ST | Synsam AB (publ) | 60.00 SEK | +6.19% | −7.21% | +9.18% |
| 7780.T | Menicon Co., Ltd. | 1,905.00 JPY | +7.99% | +22.88% | +57.22% |
| ANL | Adlai Nortye Ltd. | $13.74 | +13.93% | +895.65% | +737.80% |
| TBPH | Theravance Biopharma, Inc. | $17.03 | +1.01% | −6.17% | +23.45% |
| MCAP.ST | MedCap AB (publ) | 566.00 SEK | +3.10% | +6.19% | −8.86% |
| TALK | Talkspace, Inc. | $5.25 | +0.57% | +49.57% | +97.74% |
| BBNX | Beta Bionics, Inc. | $19.34 | +20.95% | −33.88% | +10.83% |
| SIBN | SI-BONE, Inc. | $19.54 | +14.60% | −1.26% | +21.74% |
| AVR | Anteris Technologies Global Corp. | $8.89 | +8.81% | +80.69% | +140.27% |
| RIGL | Rigel Pharmaceuticals, Inc. | $46.75 | +25.03% | +11.76% | +14.75% |
| INMD | InMode Ltd. | $15.03 | −2.28% | +1.55% | +3.16% |
| AVR.AX | Anteris Technologies Global Corp. | 12.07 AUD | +4.96% | +62.01% | +102.52% |
| 4694.T | BML, Inc. | 3,670.00 JPY | +1.66% | −2.27% | +7.64% |
| DYVOX.ST | Dynavox Group AB (publ) | 74.90 SEK | −0.07% | −23.54% | −39.04% |
| SFL.MI | Safilo Group S.p.A. | 1.88 EUR | +14.46% | −3.79% | +24.24% |
| COLL | Collegium Pharmaceutical, Inc. | $27.47 | −22.66% | −39.67% | −29.15% |
| OXB.L | Oxford Biomedica plc | 509.00 GBP | −8.45% | −22.29% | −8.62% |
| FDMT | 4D Molecular Therapeutics, Inc. | $15.72 | +51.45% | +114.75% | +133.23% |
| SLN | Silence Therapeutics plc | $13.67 | +13.26% | +122.28% | +170.16% |
| AHG | Akso Health Group | $0.98 | −32.59% | −38.49% | −44.40% |
| HSTM | HealthStream, Inc. | $28.87 | +3.59% | +27.07% | +4.49% |
| GNFT.PA | Genfit S.A. | 13.90 EUR | +5.30% | +164.76% | +293.99% |
| AMS.L | Advanced Medical Solutions Group plc | 282.00 GBP | +0.71% | +29.37% | +37.58% |
| PHAR | Pharming Group N.V. | $11.46 | −11.93% | −33.14% | −19.75% |
| APOTEA.ST | Apotea AB | 73.50 SEK | −0.41% | −18.06% | −29.63% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $3.18 | 0.00% | −14.29% | +47.91% |
| ARJO-B.ST | Arjo AB (publ) | 28.14 SEK | +4.30% | −7.67% | −17.06% |
| NGNE | Neurogene Inc. | $40.84 | +17.97% | +102.58% | +104.40% |
| ACHV | Achieve Life Sciences, Inc. | $8.17 | +32.20% | +64.39% | +146.83% |
| AURA | Aura Biosciences, Inc. | $7.82 | +9.22% | +47.55% | +19.94% |
| WELL.TO | WELL Health Technologies Corp. | 4.34 CAD | +8.77% | +7.16% | −10.70% |
| EIQ.AX | Echo IQ Limited | 1.55 AUD | +21.65% | +505.88% | +653.66% |
| STTK | Shattuck Labs, Inc. | $8.06 | +14.49% | +117.25% | +710.87% |
| SNT.WA | Synektik Spólka Akcyjna | 338.00 PLN | −6.78% | +21.68% | +53.56% |
| DRUG | Bright Minds Biosciences Inc. | $79.49 | +10.54% | −4.76% | +90.62% |
| VREX | Varex Imaging Corporation | $18.50 | +68.49% | +58.80% | +62.28% |
| NVCT | Nuvectis Pharma, Inc. | $25.89 | +32.50% | +204.23% | +298.92% |
| UU8.F | Neurogene Inc. | 32.20 EUR | +7.33% | +25.29% | +157.60% |
| 001067.KS | JW Pharmaceutical Corporation | 45,900.00 KRW | +5.88% | −21.56% | −21.42% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $9.37 | +7.09% | −23.76% | −3.50% |
| ALLO | Allogene Therapeutics, Inc. | $2.17 | +24.00% | +60.74% | +87.07% |
| MNPR | Monopar Therapeutics Inc. | $110.82 | +0.44% | +67.88% | +264.30% |
| AHCO | AdaptHealth Corp. | $5.48 | −50.00% | −43.33% | −40.63% |
| TECX | Tectonic Therapeutic, Inc. | $37.71 | +23.20% | +80.34% | +53.48% |
| SOPH | SOPHiA GENETICS SA | $8.65 | +53.10% | +85.22% | +150.72% |
| 4534.T | Mochida Pharmaceutical Co., Ltd. | 3,340.00 JPY | +4.87% | −4.62% | +8.68% |
| CTMX | CytomX Therapeutics, Inc. | $3.37 | +3.69% | −20.71% | +68.50% |
| D2OC34.SA | Doximity, Inc. | 21.20 BRL | +18.17% | −48.15% | −64.74% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $4.39 | +12.28% | +2.81% | +245.67% |
| DHT-UN.TO | DRI Healthcare Trust | 17.79 CAD | +1.95% | +11.64% | +28.36% |
| OCS | Oculis Holding AG | $12.96 | +17.60% | −35.20% | −27.15% |
| ASMB | Assembly Biosciences, Inc. | $35.33 | +36.36% | +4.68% | +32.72% |
| 4588.T | Oncolys BioPharma Inc. | 4,130.00 JPY | +65.80% | +176.44% | +526.71% |
| ZVRA | Zevra Therapeutics, Inc. | $12.04 | +24.00% | +44.36% | +28.63% |
| PHAT | Phathom Pharmaceuticals, Inc. | $8.66 | −27.53% | −44.88% | −25.15% |
| PHR | Phreesia, Inc. | $11.52 | +8.37% | −29.33% | −62.09% |
| SSII | SS Innovations International, Inc. | $3.55 | −10.35% | −37.17% | −49.14% |
| XOMA | XOMA Royalty Corp | $40.17 | 0.00% | +43.52% | +18.95% |
| 9267.T | Genky DrugStores Co., Ltd. | 3,690.00 JPY | −8.09% | −25.30% | −19.42% |
| C2RS34.SA | CRISPR Therapeutics AG | 36.81 BRL | +21.65% | +2.36% | −0.08% |
| BHVN34.SA | BIOHAVEN LTDDRN | 23.68 BRL | +3.14% | −1.09% | −18.03% |
| 7575.T | Japan Lifeline Co., Ltd. | 1,578.00 JPY | +10.81% | +1.42% | +12.56% |
| GUD.TO | Knight Therapeutics Inc. | 9.75 CAD | −0.71% | +64.97% | +49.08% |
| PROK | ProKidney Corp. | $1.73 | +12.34% | −22.42% | −26.38% |
| AGMB | AgomAb Therapeutics NV | $14.02 | +12.07% | −4.30% | −4.30% |
| DHT-U.TO | DRI Healthcare Trust | $12.56 | +0.88% | +6.68% | +27.68% |
| GMRS | GMR Solutions Inc. | $12.70 | −0.16% | −9.16% | −9.16% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.